The KDCA announced on the 14th that it will hold a joint meeting of related ministries to introduce 500 people of the antiviral drug Tecovirimat in July to respond to monkeypox.

Kwon Joon-wook, head of the National Institute of Health, made this announcement at a briefing on COVID-19. The KDCA plans to hold a meeting of the monkeypox task force jointly with related ministries later in the day. The meeting will discuss detailed plans to introduce 500 antiviral drugs to Korea in July compared to monkeypox.

The antiviral drug to be introduced is Tecovirimat, the only product licensed as a monkeypox treatment overseas. Specifically, the product name Tpoxx (Tecovirimat), has been officially ap